Prestige Wealth Management Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $479 | Buy |
+28
| New | +$479 | ﹤0.01% | 934 |
|
|
2023
Q4 | – | Sell |
-17
| Closed | -$2.06K | – | 1068 |
|
|
2023
Q3 | $2.06K | Hold |
17
| – | – | ﹤0.01% | 726 |
|
|
2023
Q2 | $1.95K | Hold |
17
| – | – | ﹤0.01% | 760 |
|
|
2023
Q1 | $2.34K | Buy |
17
+7
| +70% | +$965 | ﹤0.01% | 720 |
|
|
2022
Q4 | $1.3K | Hold |
10
| – | – | ﹤0.01% | 924 |
|
|
2022
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 914 |
|
|
2022
Q2 | $1K | Sell |
10
-26
| -72% | -$2.6K | ﹤0.01% | 919 |
|
|
2022
Q1 | $3K | Hold |
36
| – | – | ﹤0.01% | 731 |
|
|
2021
Q4 | $3K | Buy |
36
+1
| +3% | +$83 | ﹤0.01% | 749 |
|
|
2021
Q3 | $3K | Hold |
35
| – | – | ﹤0.01% | 757 |
|
|
2021
Q2 | $3K | Hold |
35
| – | – | ﹤0.01% | 752 |
|
|
2021
Q1 | $3K | Buy |
35
+14
| +67% | +$1.2K | ﹤0.01% | 742 |
|
|
2020
Q4 | $4K | Hold |
21
| – | – | ﹤0.01% | 647 |
|
|
2020
Q3 | $3K | Hold |
21
| – | – | ﹤0.01% | 643 |
|
|
2020
Q2 | $3K | Sell |
21
-4
| -16% | -$571 | ﹤0.01% | 635 |
|
|
2020
Q1 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 674 |
|